Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future
Ashley Wilder Smith(National Cancer Institute), Brad Zebrack(University of Michigan), Brandon Hayes‐Lattin(Oregon Health & Science University), Ann M. Geiger(UMass Memorial Health Care), Donald F. Blair(National Cancer Institute), Charles D. Blanke(SWOG Cancer Research Network), Nita L. Seibel(National Cancer Institute), W. Archie Bleyer(Oregon Health & Science University), James V. Tricoli(National Cancer Institute), Lynne I. Wagner(University of North Carolina at Chapel Hill), Denise Riedel Lewis(National Cancer Institute), David R. Freyer(University of Southern California), Karen Albritton(University of North Texas)
Cited by 239
Related Papers
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing <i>KIT</i>
|Journal of Clinical Oncology|2008|1k
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636